When COVID-19 struck, AbbVie’s scientists and R&D team sprang into action, partnering with leading academic institutions to better understand this pandemic and the next one, working all hours, poring over the latest scientific literature as it was published. At the same time, our operations team defined agility by making sure our millions of patients continued to receive the medicine they need and worked hard to prevent any interruption in our production.
And through the year, our diverse employees from around the globe stood united to support, inspire and champion each other. From our LGBTQ+ community helping to foster a diverse and inclusive environment to our AbbVie’s working moms and dads of the year finding innovative ways to strike work-life balance, our employees pulled together.
"The world has never seen a crisis of this magnitude and people are depending on science to answer the call,” said Tom Hudson, M.D., AbbVie’s senior vice president, R&D, chief scientific officer. “AbbVie’s scientists understand the stakes and are using our decades of expertise to help."